From Mind to Market – Launching Neurotech Innovations

​This industry panel will explore the journey from concept to commercial neurotech innovation, addressing:

• ​Building effective teams and research environments for product development

• ​Navigating the MedTech regulatory landscape

• ​Clinical validation and trials in neurotechnology

• ​⁠Overcoming common challenges faced by neurotech founders

​Panelists include:

• ​Dr. Ahmet Can Berkyurek, CEO, Cambridge Medixine Ltd.

• ​Petroula Laiou, CEO, NeuralPulse

• ​Sam Kamali, CEO, MyoNerve

• ​Yvanne Enever, CEO, PHARMExcel